IonGate starts commercialization of SURFE<sup>2</sup>R in Asia
12 Mar 2008IonGate Biosciences is expanding its operations to market the SURFE2R (SURFace Electrogenic Event Reader) Technology to the Japanese market. BRC - Bio Research Center Co. Ltd Nagoya, Japan and IonGate jointly introduce the proprietary technique to automatically screen transport proteins in high throughput at meetings in Japan, thus making the technology accessible to the Asian market.
BRC is an established partner able to supply Japan’s researchers with Life-Sciences innovations from around the world. The distribution of SURFE2R will help secure its position as a professional provider of sophisticated technologies.
IonGate has successfully launched SURFE2R Technology in both Europe and North America, and expects a growing demand for the technology in these markets. As Japanese scientists perform increasingly sophisticated research in the field of membrane proteins, especially on transport proteins, the introduction of the SURFE2R Technology is highly anticipated. This is the first step for increasing presence in the Asian market in 2008, one of the strongest growing biotech markets worldwide.
The flagship model of the product family, SURFE2R Workstation 500, will be showcased at two scientific meetings in Japan in March.